Skip to main content
NCBI home page
Heart logoLink to Heart
. 2001 Apr;85(4):463–469. doi: 10.1136/heart.85.4.463

Diabetic heart disease: clinical considerations

A Timmis 1
PMCID: PMC1729682  PMID: 11250979

Full Text

The Full Text of this article is available as a PDF (172.3 KB).

Figure 1:  .

Figure 1:  

Open in a new tab

MRFIT trial: age adjusted cardiovascular disease death rates (per 10 000 person years) by presence of number of risk factors in men with and without diabetes. Reproduced from Stamler et al3 with permission of American Diabetes Association.

Figure 2:  .

Figure 2:  

Open in a new tab

Complications of acute myocardial infarction in diabetic and non-diabetic patients (n = 1929). CVA, cerebrovascular accident; 1° VF, primary ventricular fibrillation; LVF, left ventricular failure.

Figure 3:  .

Figure 3:  

Open in a new tab

UKPDS 38 trial: relative risk reduction with tight blood pressure control.13

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ewing D. J., Boland O., Neilson J. M., Cho C. G., Clarke B. F. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia. 1991 Mar;34(3):182–185. doi: 10.1007/BF00418273. [DOI] [PubMed] [Google Scholar]
  2. Fuller J. H., Shipley M. J., Rose G., Jarrett R. J., Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) 1983 Sep 24;287(6396):867–870. doi: 10.1136/bmj.287.6396.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Granger C. B., Califf R. M., Young S., Candela R., Samaha J., Worley S., Kereiakes D. J., Topol E. J. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol. 1993 Mar 15;21(4):920–925. doi: 10.1016/0735-1097(93)90348-5. [DOI] [PubMed] [Google Scholar]
  4. Kannel W. B., McGee D. L. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979 Jan;59(1):8–13. doi: 10.1161/01.cir.59.1.8. [DOI] [PubMed] [Google Scholar]
  5. Malmberg K., Rydén L., Efendic S., Herlitz J., Nicol P., Waldenström A., Wedel H., Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995 Jul;26(1):57–65. doi: 10.1016/0735-1097(95)00126-k. [DOI] [PubMed] [Google Scholar]
  6. Mancini G. B., Henry G. C., Macaya C., O'Neill B. J., Pucillo A. L., Carere R. G., Wargovich T. J., Mudra H., Lüscher T. F., Klibaner M. I. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation. 1996 Aug 1;94(3):258–265. doi: 10.1161/01.cir.94.3.258. [DOI] [PubMed] [Google Scholar]
  7. Marchant B., Umachandran V., Stevenson R., Kopelman P. G., Timmis A. D. Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol. 1993 Nov 1;22(5):1433–1437. doi: 10.1016/0735-1097(93)90554-e. [DOI] [PubMed] [Google Scholar]
  8. Marso S. P., Lincoff A. M., Ellis S. G., Bhatt D. L., Tanguay J. F., Kleiman N. S., Hammoud T., Booth J. E., Sapp S. K., Topol E. J. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy. Circulation. 1999 Dec 21;100(25):2477–2484. doi: 10.1161/01.cir.100.25.2477. [DOI] [PubMed] [Google Scholar]
  9. Ranjadayalan K., Umachandran V., Ambepityia G., Kopelman P. G., Mills P. G., Timmis A. D. Prolonged anginal perceptual threshold in diabetes: effects on exercise capacity and myocardial ischemia. J Am Coll Cardiol. 1990 Nov;16(5):1120–1124. doi: 10.1016/0735-1097(90)90543-x. [DOI] [PubMed] [Google Scholar]
  10. Soläng L., Malmberg K., Rydén L. Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J. 1999 Jun;20(11):789–795. doi: 10.1053/euhj.1998.1472. [DOI] [PubMed] [Google Scholar]
  11. Stamler J., Vaccaro O., Neaton J. D., Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993 Feb;16(2):434–444. doi: 10.2337/diacare.16.2.434. [DOI] [PubMed] [Google Scholar]
  12. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000 Jan 20;342(3):145–153. doi: 10.1056/NEJM200001203420301. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES